T 0967/16 (Oxcarbazepine Stevens-Johnson Syndrome/ACADEMIA SINICA PHARMIGENE) of 04.08.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T096716.20200804
- Date of decision
- 4 August 2020
- Case number
- T 0967/16
- Petition for review of
- -
- Application number
- 07797432.7
- IPC class
- C12Q 1/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR PREDICTING A RISK OF ADVERSE DRUG REACTIONS BY DETERMINATION OF HLA-B 1502
- Applicant name
- Academia Sinica
Pharmigene Inc. - Opponent name
- ZBM Patents ApS
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2020)Rules of procedure of the Boards of Appeal Art 13(2) (2020)
- Keywords
- Main request (claims as granted) - inventive step (no);
Auxiliary requests 1 to 7 - withdrawn;
Auxiliary request 8 - admission in appeal (no); - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.